Efficacy and Safety of Tamibarotene (OAM80) for Alzheimer's Disease

NCT01120002 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Alzheimer's Disease

Interventions

DRUG: Tamibarotene
DRUG: Placebo

Sponsor

Osaka City University